First In Human Safety, Pharmacokinetics and Anti-tumoral Activity of GM102 in Gynecological Cancers

NCT02978755 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasm, Gynecologic

Interventions

DRUG: GM102
DRUG: GM102 escalating doses
DRUG: GM102

Sponsor

GamaMabs Pharma